Published in Blood Weekly, August 19th, 2004
According to a study from England, "Adult cardiac surgery has an incidence of 1-1.25 million procedures per year. Overall costs are in the range of US$50 billion per year and are increasing."
"Included in these costs is an increasing burden from the use of blood and blood products. The central hemostatic problems associated with cardiac surgery are impaired platelet function associated with preoperative medication and cardiopulmonary bypass, consumption of platelets, dilution of coagulation proteins, and triggering of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.